Application no. and date | 04027037.3 (espacenet) (Federated) (European Patent Register), 20001211 | Patent/reg. no. and date | DK/EP 1526132, 20140312 | Publication date | 20050427 | Priority no. and date | DE 19962924, 19991224 | EP pub. no. and date |
EP 1526132 20050427 | Effective date | | Applicant/owner | Bayer Intellectual Property GmbH, Alfred-Nobel-Str. 50 40789 Monheim am Rhein, DE | Applicant ref. no. | BBS LeA34122-EP01 | Inventor | Straub, Alexander, Dr., Wotanstrasse 13
42117 Wuppertal, DE, Lampe, Thomas, Dr., Karolingerstrasse 93
40223 Düsseldorf, DE, Pohlmann, Jens, Dr., Fischerweg 3
4058 Basel, CH, Röhrig, Susanne, Dr., Buschstrasse 20
45276 Essen, DE, Perzborn, Elisabeth, Dr., Am Tescher Busch 13
42327 Wuppertal, DE, Schlemmer, Karl-Heinz, Dr., Wildsteig 22a
42113 Wuppertal, DE, Pernerstorfer, Joseph, Dr., Gerresheimer Strasse 9
40721 Hilden, DE | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/42 (2006.01) , A61P 7/00 (2006.01) , C07D 413/12 (2006.01) , C07D 413/14 (2006.01) , C07D 417/14 (2006.01) | Title | Substituerede oxazolidinoner og deres anvendelse som faktor Xa-hæmmer | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|